Despite advances in the treatment of rare diseases, the bureaucracy surrounding the FDA refuses to adapt to the current means of medical innovation. The 21st Century Cures Act would help to modernize the FDA approval process and increase patient access to novel therapies.
Although Obamacare continues to show symptoms of poor policy, conservative reform efforts must move pass mere calls for repeal and engage in a meaningful dialogue that seeks to limit the law’s harm.
Covering a health story today? Here’s the latest from the experts on the AEI health team.
The Republican Party has stated where it stands on health care and other policy issues. It remains to be seen where their candidate lands on those same issues.
In this working paper, the authors study state laws that limit hospital prices for uninsured patients. The laws lead to clear reductions in the amount of care delivered to uninsured patients, but no deterioration in quality of care. The paper provides strong evidence that hospitals actively alter their behavior in response to financial incentives.
Obama’s recent article in JAMA fails to provide an accurate assessment of the ACA. A closer look reveals an unstable system, where the government plays an increasing role and patients are left with limited options.
Dr. Gottlieb stresses the importance of innovation within health care delivery systems as a means to maximize the benefits of every dollar spent. Unfortunately, current Medicare polices create obstacles to innovation by scrutinizing profit margins and adjusting reimbursement schedules to diminish ‘excess profitability.’ Such actions discourage investment in new medical technologies and exacerbate current health financing woes.
Current regulation discourages the value-based purchasing of drugs, potentially stifling both competition and innovation. Sensible reform would adopt a market-oriented approach where drug prices reflect actual clinical outcomes.
This paper assesses the quality of 1,470 antibiotic and tuberculosis drug samples in solid oral form that claim to be made in India and were sold in Africa, India, and five mid-income non-African countries. We find that 10.9 percent of those products fail a basic assessment of active pharmaceutical ingredients (API), and the majority of the failures are substandard (7 percent) as they contain some correct API but the amount of API is underdosed.
The House GOP health plan released last month by Speaker Ryan represents an essential starting point for reforming the precarious government foundation propping up the ACA.